62310 Federal Register / Vol. 74, No. 227 / Friday, November 27, 2009 / Notices STATUS: This meeting will be open to the www.ftc.gov/os/caselist/0910053/ development information, and public. index.shtm, and may also be secured regulatory materials, as well as two of ITEMS TO BE DISCUSSED: from the following address: Federal Fort Dodge’s three U.S. manufacturing Correction and Approval of Minutes. Trade Commission, Consumer Response facilities. These divestitures fully Notice of Proposed Rulemaking on Center, Public Reference Room, Room preserve the competition that the Federal Officeholder’s and Candidates’ H–130, 600 Pennsylvania Avenue, NW., proposed acquisition would otherwise Participation in Certain Non-Federal Washington, DC 20580. eliminate. Fundraising Events. FOR FURTHER INFORMATION CONTACT: The proposed Consent Agreement has Final Rules on Campaign Travel. Michael R. Moiseyev, Bureau of been placed on the public record for Consideration of Policy to Place First Competition, 600 Pennsylvania Avenue, thirty days for receipt of comments by General Counsel’s Reports on the Public NW., Washington, DC 20580, (202) 326– interested persons. Comments received Record. 3106. during this period will become part of Adoption of Policy to Prepare and SUPPLEMENTARY INFORMATION: Pursuant the public record. After thirty days, the Publish a Guidebook for Complainants to section 6(f) of the Federal Trade Commission will again review the and Respondents in Enforcement Commission Act, 38 Stat. 721, 15 U.S.C. proposed Consent Agreement and the Matters. 46(f), and § 2.34 the Commission Rules comments received to decide whether it Co-sponsorship of 2010 COGEL of Practice, 16 CFR 2.34, notice is should withdraw from the proposed Annual Meeting. hereby given that the above-captioned Consent Agreement, modify it, or make Management and Administrative consent agreement containing a consent final the accompanying Decision and Matters. order to cease and desist, having been Order (‘‘Order’’). Individuals who plan to attend and filed with and accepted, subject to final Pursuant to an Agreement and Plan of require special assistance, such as sign approval, by the Commission, has been Merger dated as of January 25, 2009, language interpretation or other placed on the public record for a period Pfizer proposes to acquire all of the reasonable accommodations, should of thirty (30) days. The following issued and outstanding shares of Wyeth, contact Mary Dove, Commission Analysis to Aid Public Comment whereby each outstanding share of Secretary, at (202) 694–1040, at least 72 describes the terms of the consent Wyeth common stock will be converted hours prior to the hearing date. agreement, and the allegations in the into the right to receive $33 in cash and PERSON TO CONTACT FOR INFORMATION: complaint. An electronic copy of the 0.985 share of Pfizer common stock. Judith Ingram, Press Officer, Telephone: full text of the consent agreement Both parties manufacture human and (202) 694–1220. package can be obtained from the FTC animal health biological and Home Page (for October 14, 2009), on pharmaceutical products. The combined Mary W. Dove, the World Wide Web, at http:// firm would have projected worldwide Secretary of the Commission. www.ftc.gov/opa/2009/10/pfizer.shtm. revenues of almost $72 billion. The [FR Doc. E9–27976 Filed 11–25–09; 8:45 am] A paper copy can be obtained from the Commission’s complaint alleges that the BILLING CODE 6715–01–M FTC Public Reference Room, Room 130– proposed acquisition, if consummated, H, 600 Pennsylvania Avenue, NW., would violate Section 7 of the Clayton Washington, DC 20580, either in person Act, as amended, 15 U.S.C. 18, and FEDERAL TRADE COMMISSION or by calling (202) 326–2222. Section 5 of the Federal Trade Commission Act, as amended, 15 U.S.C. [File No. 091 0053] Analysis of Proposed Agreement Containing Consent Orders To Aid 45, in U.S. markets for the manufacture Pfizer Inc. and Wyeth; Analysis of Public Comment and sale of: (1) Killed cattle respiratory Agreement Containing Consent Order vaccines; (2) modified-live cattle I. Introduction To Aid Public Comment and Statement respiratory vaccines; (3) cattle of the Federal Trade Commission The Federal Trade Commission reproductive vaccines; (4) cattle (‘‘Commission’’) has accepted, subject to pasteurella vaccines; (5) lactating-cow AGENCY: Federal Trade Commission. final approval, an Agreement mastitis treatments; (6) dry-cow mastitis ACTION: Notice of acceptance of consent Containing Consent Orders (‘‘Consent treatments; (7) dairy cattle broad- agreement. Agreement’’) with Pfizer Inc. (‘‘Pfizer’’), spectrum antibiotics with low milk- which is designed to remedy the withholding times; (8) cattle SUMMARY: The consent agreement in this anticompetitive effects of its proposed macrocyclic lactone parasiticides; (9) matter settles alleged violations of acquisition of Wyeth. Under the terms cattle benzimidazole parasiticides; (10) Federal law prohibiting unfair or of the Consent Agreement, Pfizer must canine combination vaccines; (11) deceptive acts or practices or unfair divest to Boehringer Ingelheim canine monovalent parvovirus vaccines; methods of competition. The attached Vetmedica, Inc. (‘‘BI’’) Wyeth’s U.S. (12) canine monovalent coronavirus Analysis to Aid Public Comment animal health business (‘‘Fort Dodge’’) vaccines; (13) canine monovalent describes both the allegations in the in all areas of overlap, except for equine leptospira vaccines; (14) canine complaint and the terms of the consent tapeworm parasiticides and equine bordetella vaccines; (15) feline order—embodied in the consent herpesvirus vaccines. In the area of combination vaccines; (16) feline agreement—that settle these allegations. equine tapeworm parasiticides, the leukemia vaccines; (17) companion ADDRESSES: Copies of the Statement of consent order requires Pfizer to return to animal rabies vaccines; (18) companion the Commission, the Agreement Virbac S.A. (‘‘Virbac’’) Pfizer’s exclusive animal cephalosporin antibiotics; (19) Containing Consent Orders, the distribution rights for these products. In equine tapeworm parasiticides Decision and Order (Redacted Public the area of equine herpesvirus vaccines, containing praziquantel; (20) equine Version), the Order To Maintain Assets, Pfizer is ordered to divest to BI Pfizer’s herpesvirus vaccines; and (21) equine the Complaint, the Analysis To Aid equine herpesvirus products. The assets joint-injected steroids. The proposed Public Comment, and other materials for each of the divestitures include all Consent Agreement remedies the may be found on the Federal Trade of the relevant intellectual property, alleged violations by replacing in each Commission Web site, at http:// customer lists, research and of the relevant markets the lost VerDate Nov<24>2008 18:08 Nov 25, 2009 Jkt 220001 PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 E:\FR\FM\27NON1.SGM 27NON1 sroberts on DSKD5P82C1PROD with NOTICES Federal Register / Vol. 74, No. 227 / Friday, November 27, 2009 / Notices 62311 competition that would result from the and Fort Dodge account for over 53 that affect dairy cows.1 Pfizer’s products acquisition. percent of all modified-live respiratory are considered the most effective antibiotics for dairy cows and have a II. The Products and Structure of the vaccine sales in the United States. As zero-day withholding period, while Fort Markets with killed respiratory vaccines, the 5- way modified-live respiratory vaccine is Dodge’s product has a low withholding The proposed acquisition of Wyeth by the most commonly used modified-live period of two to four days. A generic Pfizer would combine two of the largest cattle respiratory vaccine. As a result of version of one of Pfizer’s products was animal health suppliers in the United the proposed acquisition, Pfizer would recently introduced. As a result of the States. The companies overlap in control over 68 percent of the 5-way proposed acquisition, Pfizer would have several animal health markets, and, if modified-live respiratory vaccine a near monopoly in this $162 million consummated, the transaction likely market. market. would lead to anticompetitive effects in Cattle macrocyclic lactone each of the relevant markets. More Cattle reproductive vaccines are used parasiticides are the newest and most specifically, the transaction would to prevent early- and late-stage abortions effective class of cattle parasiticides in decrease the number of competing in pregnant cattle. The markets for cattle suppliers in the overlap markets, which reproductive vaccines include, most the United States. They are effective number has a direct and substantial significantly: (1) The market for against both internal and external effect on the prices of animal health modified-live 10-way vaccines, which parasites. There are only three branded products. The evidence shows that contain modified-live viral respiratory players in the $118 million U.S. market: customers are able to obtain lower and Leptospira antigens; (2) the market Pfizer, Fort Dodge, and Merial. prices by threatening to switch to for killed 10-way vaccines, which Although generic versions of Merial’s another supplier or presenting the contain killed viral respiratory and product are available, there are no incumbent supplier with a rival’s lower Leptospira antigens; and (3) the market generic versions of Pfizer’s or Fort offer. Customers have stated that they for lepto/vibrio vaccines, which contain Dodge’s products currently on the generally can negotiate lower prices